Literature DB >> 25156740

Hydrogen peroxide production from glycerol metabolism is dispensable for virulence of Mycoplasma gallisepticum in the tracheas of chickens.

S M Szczepanek1, M Boccaccio1, K Pflaum1, X Liao1, S J Geary2.   

Abstract

Hydrogen peroxide (H2O2) is a by-product of glycerol metabolism in mycoplasmas and has been shown to cause cytotoxicity for cocultured eukaryotic cells. There appears to be selective pressure for mycoplasmas to retain the genes needed for glycerol metabolism. This has generated interest and speculation as to their function during infection. However, the actual effects of glycerol metabolism and H2O2 production on virulence in vivo have never been assessed in any Mycoplasma species. To this end, we determined that the wild-type (WT) R(low) strain of the avian pathogen Mycoplasma gallisepticum is capable of producing H2O2 when grown in glycerol and is cytotoxic to eukaryotic cells in culture. Transposon mutants with mutations in the genes present in the glycerol transport and utilization pathway, namely, glpO, glpK, and glpF, were identified. All mutants assessed were incapable of producing H2O2 and were not cytotoxic when grown in glycerol. We also determined that vaccine strains ts-11 and 6/85 produce little to no H2O2 when grown in glycerol, while the naturally attenuated F strain does produce H2O2. Chickens were infected with one of two glpO mutants, a glpK mutant, R(low), or growth medium, and tracheal mucosal thickness and lesion scores were assessed. Interestingly, all glp mutants were reproducibly virulent in the respiratory tracts of the chickens. Thus, there appears to be no link between glycerol metabolism/H2O2 production/cytotoxicity and virulence for this Mycoplasma species in its natural host. However, it is possible that glycerol metabolism is required by M. gallisepticum in a niche that we have yet to study.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156740      PMCID: PMC4249280          DOI: 10.1128/IAI.02208-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  DIRECT AGAR ISOLATION OF MYCOPLASMAS FROM HUMAN LEUKAEMIC BONE MARROW.

Authors:  L HAYFLICK; H KOPROWSKI
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

2.  The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low).

Authors:  Leka Papazisi; Timothy S Gorton; Gerald Kutish; Philip F Markham; Glenn F Browning; Di Kim Nguyen; Steven Swartzell; Anup Madan; Greg Mahairas; Steven J Geary
Journal:  Microbiology       Date:  2003-09       Impact factor: 2.777

3.  Antiphospholipid antibodies and Mycoplasma pneumoniae infection.

Authors:  N Snowden; P B Wilson; M Longson; R S Pumphrey
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

4.  Diversity of energy-yielding substrates and metabolism in avian mycoplasmas.

Authors:  R R Taylor; K Mohan; R J Miles
Journal:  Vet Microbiol       Date:  1996-08       Impact factor: 3.293

5.  Hydrogen peroxide production by Mycoplasma bovis and Mycoplasma agalactiae and effect of in vitro passage on a Mycoplasma bovis strain producing high levels of H2O2.

Authors:  L A Khan; R J Miles; R A J Nicholas
Journal:  Vet Res Commun       Date:  2005-04       Impact factor: 2.459

6.  A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony.

Authors:  Paola Pilo; Edy M Vilei; Ernst Peterhans; Laetitia Bonvin-Klotz; Michael H Stoffel; Dirk Dobbelaere; Joachim Frey
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

7.  Fructose utilization and phytopathogenicity of Spiroplasma citri.

Authors:  P Gaurivaud; J L Danet; F Laigret; M Garnier; J M Bové
Journal:  Mol Plant Microbe Interact       Date:  2000-10       Impact factor: 4.171

8.  Rapid screening of H(2)O(2) production by Mycoplasma mycoides and differentiation of European subsp. mycoides SC (small colony) isolates.

Authors:  P Rice; B M Houshaymi; E A Abu-Groun; R A Nicholas; R J Miles
Journal:  Vet Microbiol       Date:  2001-02-26       Impact factor: 3.293

9.  Pen trial studies on the use of live vaccines to displace virulent Mycoplasma gallisepticum in chickens.

Authors:  S H Kleven; H H Fan; K S Turner
Journal:  Avian Dis       Date:  1998 Apr-Jun       Impact factor: 1.577

10.  Semi-automated curation of metabolic models via flux balance analysis: a case study with Mycoplasma gallisepticum.

Authors:  Eddy J Bautista; Joseph Zinski; Steven M Szczepanek; Erik L Johnson; Edan R Tulman; Wei-Mei Ching; Steven J Geary; Ranjan Srivastava
Journal:  PLoS Comput Biol       Date:  2013-09-05       Impact factor: 4.475

View more
  15 in total

1.  Variable Lipoprotein Hemagglutinin A Gene (vlhA) Expression in Variant Mycoplasma gallisepticum Strains In Vivo.

Authors:  K Pflaum; E R Tulman; J Beaudet; J Canter; S J Geary
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

2.  Proteases as Secreted Exoproteins in Mycoplasmas from Ruminant Lungs and Their Impact on Surface-Exposed Proteins.

Authors:  Sarah Ganter; Guylaine Miotello; Lucía Manso-Silván; Jean Armengaud; Florence Tardy; Patrice Gaurivaud; François Thiaucourt
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

3.  Comparative evaluation of different therapeutic protocols for contagious caprine pleuropneumonia in Himalayan Pashmina goats.

Authors:  Mohd Iqbal Yatoo; Oveas Raffiq Parray; Muheet Mir; Riyaz Ahmed Bhat; Hamid Ullah Malik; Mujeeb Ur Rehman Fazili; Sabia Qureshi; Masood Salim Mir; Raja Wasim Yousuf; Noor Alam Tufani; Kuldeep Dhama; Shah Tauseef Bashir
Journal:  Trop Anim Health Prod       Date:  2019-05-10       Impact factor: 1.893

4.  Phase Transition of the Bacterium upon Invasion of a Host Cell as a Mechanism of Adaptation: a Mycoplasma gallisepticum Model.

Authors:  Daria Matyushkina; Olga Pobeguts; Ivan Butenko; Anna Vanyushkina; Nicolay Anikanov; Olga Bukato; Daria Evsyutina; Alexandra Bogomazova; Maria Lagarkova; Tatiana Semashko; Irina Garanina; Vladislav Babenko; Maria Vakhitova; Valentina Ladygina; Gleb Fisunov; Vadim Govorun
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

5.  Mycoplasma bovis NADH oxidase functions as both a NADH oxidizing and O2 reducing enzyme and an adhesin.

Authors:  Gang Zhao; Hui Zhang; Xi Chen; Xifang Zhu; Yusi Guo; Chenfei He; Farhan Anwar Khan; Yingyu Chen; Changmin Hu; Huanchun Chen; Aizhen Guo
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

6.  Mycoplasma hyopneumoniae surface-associated proteases cleave bradykinin, substance P, neurokinin A and neuropeptide Y.

Authors:  Veronica Maria Jarocki; Benjamin Bernard Armando Raymond; Jessica Leigh Tacchi; Matthew Paul Padula; Steven Philip Djordjevic
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  Removal of a Subset of Non-essential Genes Fully Attenuates a Highly Virulent Mycoplasma Strain.

Authors:  Joerg Jores; Li Ma; Paul Ssajjakambwe; Elise Schieck; Anne Liljander; Suchismita Chandran; Michael H Stoffel; Valentina Cippa; Yonathan Arfi; Nacyra Assad-Garcia; Laurent Falquet; Pascal Sirand-Pugnet; Alain Blanchard; Carole Lartigue; Horst Posthaus; Fabien Labroussaa; Sanjay Vashee
Journal:  Front Microbiol       Date:  2019-04-03       Impact factor: 5.640

8.  Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors.

Authors:  Maria Lluch-Senar; Luca Cozzuto; Jaime Cano; Javier Delgado; Verónica Llórens-Rico; Sabine Pereyre; Cécile Bebear; Luis Serrano
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

9.  Complete Genome Sequence of Mycoplasma flocculare Strain Ms42T (ATCC 27399T).

Authors:  Michael J Calcutt; Mark F Foecking; Manijeh B Heidari; Mark A McIntosh
Journal:  Genome Announc       Date:  2015-03-12

10.  Mycoplasma ovipneumoniae induces sheep airway epithelial cell apoptosis through an ERK signalling-mediated mitochondria pathway.

Authors:  Yanan Li; Zhongjia Jiang; Di Xue; Guangcun Deng; Min Li; Xiaoming Liu; Yujiong Wang
Journal:  BMC Microbiol       Date:  2016-09-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.